Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Zentalis Pharmaceuticals
530 Seventh Avenue Suite 2201
New York, NY 10018
https://www.zentalis.com/

Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics that target fundamental biological pathways in cancer. In addition to its lead program, ZN-c5, an oral SERD for estrogen receptor positive, HER2-negative breast cancer, the Company is developing a broad pipeline of oncology candidates, targeting areas of major unmet medical need. The Company has offices in New York and San Diego.

Key Contact
Name
Anthony Sun
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
12/09/19 $85,000,000 Series C Eventide Asset Management
Farallon Capital Management
Matrix Capital Management
Perceptive Advisors
Redmile Group
Surveyor Capital
Viking Global Investors
undisclosed


Featured Reading